TITLE

Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI

AUTHOR(S)
Chou, C. T.; Chen, R. C.; Chen, W. T.; Lii, J.-M.
PUB. DATE
December 2010
SOURCE
British Journal of Radiology;Dec2010, Vol. 83 Issue 996, p1023
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of this study was to determine the percentage of signal intensity loss (PSIL) threshold for the characterisation of focal liver lesions among patients with chronic liver disease. 55 nodules in 49 patients with chronic liver disease who underwent ferucarbotran-enhanced MR studies were included. Among the 49 patients, 40 had liver cirrhosis and 9 had chronic hepatitis. 8 haemangiomas, 3 focal nodular hyperplasia, 9 dysplastic nodules and 12 well, 19 moderately and 4 poorly differentiated hepatocellular carcinomas (HCCs) were revealed. The PSIL, signal-to-noise ratio and contrast-to-noise ratio of each lesion type were calculated. The diagnostic performance of PSIL on ferucarbotran-enhanced T2 weighted images (PSILT2WI) and T2 weighted fat-suppression images (PSILFS-T2WI) that characterised hepatic tumours was compared with receiver operating characteristic (ROC) analysis. Using ROC analysis, the diagnostic performance of PSILFS-T2WI was superior to that of PSILT2WI (p=0.01). The mean PSILFS-T2WI of the benign lesions was significantly higher than that of HCC (p<0.001), and the mean PSILFS-T2WI of well-differentiated HCC was significantly higher than that of moderately/poorly differentiated HCCs (p=0.001). With a PSILFS-T2WI threshold of 40% in lesions characterising ferucarbotran-enhanced FS-T2WI, the sensitivity, specificity, accuracy, positive predictive value and negative predictive value were 88.6%, 95%, 90.9%, 96.9% and 82.6%, respectively. In conclusion, with ferucarbotran-enhanced FS-T2WI, a PSILFS-T2WI threshold of 40% for characterising focal liver nodules among patients with chronic liver disease is recommended. It is useful for distinguishing HCC from benign nodules.
ACCESSION #
57934373

 

Related Articles

  • Small Hypervascular Hepatocellular Carcinoma: Limited Value of Portal and Delayed Phases on Dynamic Magnetic Resonance Imaging. J. S. Yu; J. H. Lee; J. J. Chung; J. H. Kim; K. W. Kim // Acta Radiologica;Sep2008, Vol. 49 Issue 7, p735 

    Background: Characterization of small nodules in the cirrhotic liver is always challenging in clinical practice. In the differential diagnosis of small hypervascular lesions, it has been reported that portal venous or delayed hypointensity is a useful sign to characterize hepatocellular...

  • Guest editor's introduction: Hepatocellular nodules in liver cirrhosis: imaging update 2011. Choi, B. // Abdominal Imaging;May2011, Vol. 36 Issue 3, p230 

    These review articles will enhance the knowledge of radiologists about current imaging modalities and various contrast agents for the detection and characterization hepatocellular nodules including hepatocellular carcinoma (HCC) in liver cirrhosis, and new concepts of imaging findings, and...

  • Imaging of HCC. Ayuso, Carmen; Rimola, Jordi; García-Criado, Ángeles // Abdominal Imaging;Apr2012, Vol. 37 Issue 2, p215 

    Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends...

  • Imaging Surveillance of Hypervascular Liver Lesions in Non-Cirrhotic Patients. Chun, Yun; Parker, Robin; Inampudi, Subbarao; Ehrenwald, Eduardo; Batts, Kenneth; Burgart, Lawrence; Schumacher, Clark; Mehling, Jason; Engstrom, Bjorn; Hill, Mark; Reddy, Srinevas; Sielaff, Timothy; Chun, Yun Shin; Parker, Robin J; Batts, Kenneth P; Burgart, Lawrence J; Schumacher, Clark W; Mehling, Jason A; Engstrom, Bjorn I; Hill, Mark J // Journal of Gastrointestinal Surgery;Mar2016, Vol. 20 Issue 3, p564 

    A consensus surveillance protocol is lacking for non-cirrhotic patients with hypervascular liver lesions presumed to represent hepatocellular adenomas. Patients with hypervascular liver lesions <5 cm not meeting criteria for focal nodular hyperplasia or hepatocellular carcinoma underwent...

  • MRI findings of corticosubcortical lesions in osmotic myelinolysis: report of two cases. Tatewaki, Y.; Kato, K.; Tanabe, Y.; Takahashi, S. // British Journal of Radiology;Apr2012, Vol. 85 Issue 1012, pe87 

    Reports on the MRI findings of cerebral corticosubcortical lesions in osmotic myelinolysis (OM) are rare despite several pathological descriptions of this involvement. We report two patients with subcortical lesions associated with OM that were characteristically distributed along the crowns and...

  • Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: A Meta-Analysis. Liu, Xijiao; Zou, Li; Liu, Fei; Zhou, Yin; Song, Bin // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Objective: To determine the accuracy of MR imaging with gadoxetic acid disodium (Gd-EOB-DTPA) for the detection of hepatocelluar carcinoma (HCC). Materials and Methods: A systematic search was performed in PUBMED, EMBASE, Web of Science, Cochrane Library and the Chinese Biomedical Literature...

  • Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression. Cha, Jihoon; Kim, Sung; Kim, Hyung-Jin; Kim, Hye; Kim, Byung-joon; Jeon, Pyoung; Kim, Keon; Byun, Hong // European Radiology;Mar2013, Vol. 23 Issue 3, p879 

    Objectives: To evaluate the added value of diffusion-weighted imaging (DWI) to perfusion-weighted imaging (PWI) for differentiating tumour progression from radiation necrosis. Methods: Sixteen consecutive patients who underwent removal of a metastatic brain tumour that increased in size after...

  • Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Kogita, Sachiyo; Imai, Yasuharu; Okada, Masahiro; Kim, Tonsok; Onishi, Hiromitsu; Takamura, Manabu; Fukuda, Kazuto; Igura, Takumi; Sawai, Yoshiyuki; Morimoto, Osakuni; Hori, Masatoshi; Nagano, Hiroaki; Wakasa, Kenichi; Hayashi, Norio; Murakami, Takamichi // European Radiology;Oct2010, Vol. 20 Issue 10, p2405 

    Objective:: To retrospectively investigate enhancement patterns of hepatocellular carcinoma (HCC) and dysplastic nodule (DN) in the hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine (Gd-EOB-DTPA)-enhanced MRI in relation to histological grading and portal blood flow. Methods::...

  • Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma. An, Chansik; Park, Mi-Suk; Kim, Dowhan; Kim, Yeo-Eun; Chung, Woo-Suk; Rhee, Hyungjin; Kim, Myeong-Jin; Kim, Ki // European Radiology;Apr2013, Vol. 23 Issue 4, p924 

    Objectives: To determine the importance of arterial enhancement in diagnosing small (<3 cm) hepatocellular carcinomas (HCCs) and to evaluate the added value of dynamic subtraction magnetic resonance imaging (MRI) in detecting arterial enhancement in small (<3 cm) hepatic nodules in high-risk...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics